The Pharmacy Times® Retail Clinical Role section is a comprehensive resource for clinical news and expert insights on issues pertaining to retail, community, and independent pharmacists.
May 1st 2025
In clinical trials, the dihydroergotamine (DHE) nasal powder had favorable safety profiles and rapid pain relief in patients with migraine with or without aura.
Multiple Sclerosis Therapy for Pediatric Patients Approved by FDA
May 12th 2018Officials with the FDA have approved fingolimod (Gilenya, Novartis) for the treatment of relapsing multiple sclerosis in pediatric patients aged 10 years and older, making it the first FDA-approved drug to treat MS in this population.
Read More
President Trump Urges More Competition to Lower Drug Costs
May 12th 2018The President also noted he has directed officials to take actions to end what he termed "global freeloading," which he explained as lowered prices on drugs in other countries compared with the United States, where much of the investment funds for medical research originate.
Read More
A New, Unique Frame for Population Health Management
May 11th 2018CVS Health's Chief Medical Officer Troyen A. Brennan, MD, outlined how the combination of data-driven insights, and the convenience of community-based retail health care can provide a highly personalized health care experience that supports the primary care medical home, and can improve patient outcomes and lower costs.
Read More
Researchers and Clinicians Confront Today's HIV Profile
May 9th 2018The Conference on Retroviruses and Opportunistic Infections (CROI) annually assembles researchers from around the world to share the latest studies, important developments, and best research methods in the ongoing battle against HIV/AIDS, and related infectious diseases.
Read More
FDA Approves Drug Combination for Treating BRAF-positive Anaplastic Thyroid Cancer
May 7th 2018The FDA has approved Novartis’ combination treatment dabrafenib (Tafinlar) and trametinib (Mekinist) for the treatment of BRAF V600 mutation-positive anaplastic thyroid cancer (ATC) that cannot be removed by surgery or is metastatic.
Read More